Holen Sie sich die Stockscreener-App
7.58
6.77%
-0.55
Handel nachbörslich:
7.68
0.10
+1.32%
Schlusskurs vom Vortag:
$8.13
Offen:
$7.55
24-Stunden-Volumen:
22,561
Relative Volume:
1.80
Marktkapitalisierung:
$66.18M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+1.47%
1M Leistung:
-9.55%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$7.55
$8.15
1-Wochen-Bereich:
$7.23
$8.19
52-Wochen-Spanne:
$6.50
$9.55
Scienture Holdings Inc Stock (SCNX) Company Profile
Firmenname
Scienture Holdings Inc
Sektor
Branche
Telefon
(800) 261 0281
Adresse
2420 BRUNELLO TRACE, LUTZ
Vergleichen Sie SCNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
7.58 | 66.18M | 0 | 0 | 0 | 0.00 |
|
WBA
Walgreens Boots Alliance Inc
|
9.55 | 8.25B | 147.66B | -8.64B | -363.00M | -10.01 |
|
HITI
High Tide Inc
|
3.01 | 242.84M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
4.97 | 102.70M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
CJJD
China Jo Jo Drugstores Inc
|
1.66 | 10.26M | 148.81M | -21.14M | 0 | -0.9969 |
Scienture Holdings Inc Aktie (SCNX) Neueste Nachrichten
Scienture Holdings, Inc. to Participate in The Microcap Conference 2025 - Nasdaq
Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025 - GlobeNewswire
Scienture Holdings to Present at Microcap Conference 2025: Strategic Growth Plans in Focus - StockTitan
Trxade Group, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 - Marketscreener.com
Trxade Group, Inc. acquired Community Specialty Pharmacy, LLC from Nikul Panchal for $0.6 million. - Marketscreener.com
Amazon.com Inc (AMZN-Q) QuotePress Release - The Globe and Mail
Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041 - GlobeNewswire
Scienture Secures Crucial Patent Protection for Novel Losartan Oral Suspension Through 2041 - StockTitan
Scienture Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Scienture announces private placement of $3M of 10% secured convertible debentures - MSN
Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry into $50 Million Equity Line of Credit Agreement - The Manila Times
Scienture Holdings Secures Funding for Strategic Growth - TipRanks
Scienture Holdings Secures $62M in Strategic Financing, Including $12.2M Debenture Deal | SCNX Stock News - StockTitan
Walgreens Boots Alliance (WBA) Stock Surges Amid Market Activity - GuruFocus.com
Scienture Holdings: Q3 Earnings Snapshot - CTPost
White Mountains: Q3 Earnings Snapshot - AOL
Scienture completes preferred stock conversion By Investing.com - Investing.com Australia
Scienture completes preferred stock conversion - Investing.com India
Scienture : Material Event Form 8 K - Marketscreener.com
Scienture Holdings Shares Insight with Investor Presentation - TipRanks
Gajan A. Mahendiran and Amudha Mahendiran acquired Westminster Pharmaceutical LLC from Trxade Group, Inc. for $1.6 million. - Marketscreener.com
Top Premarket Gainers - Marketscreener.com
Scienture Holdings Unveils New Identity Post-Merger - TipRanks
TRxADE Health changes its name to Scienture Holdings - AlphaStreet
Bats Reveal Superior Adaptation to Endure Heart Stress: National Heart Centre Singapore Partners Paratus Sciences Singapore to Accelerate Heart Failure Care - ForexTV.com
Nectero Medical Recognized as a 2024 AZBio Fast Lane Award Winner - ForexTV.com
TRxADE Health rebrands as Scienture Holdings with new ticker SCNX - Investing.com
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX” - Morningstar
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - ForexTV.com
Trxade Health announces name change to Scienture Holdings - TipRanks
Guardian Pharmacy seeks to raise up to $108 mil in US IPO - AlphaStreet
Everything you need to know about Zenas BioPharma’s IPO - AlphaStreet
Trxade Group’s Strategic Merger and Rebranding as Scienture Holdings - TipRanks
TRxADE HEALTH completes all-stock merger deal with Scienture - World Pharmaceutical Frontiers
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - StockTitan
Envoy Medical is well-positioned to gain market share in hearing implant space: CEO - AlphaStreet
AgEagle’s latest focus is on tailoring products for defense, public safety industries: CEO - AlphaStreet
TRxADE Health, Inc. Announces Special Cash Dividend | MEDS Stock News - StockTitan
Everything you need to know about OS Therapies’ upcoming IPO - AlphaStreet
MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results - AlphaStreet
TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale - StockTitan
Alumis looks to raise $300 million in IPO. Here’s what you need to know - AlphaStreet
Tempus AI gears up for IPO. Here’s everything you need to know - AlphaStreet
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary - AlphaStreet
Femasys is committed to providing women with revolutionary healthcare products: CEO - AlphaStreet
Trxade Health, Inc. Announces Special Cash Dividend, Payable on or About March 22, 2024 - Marketscreener.com
Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary - AlphaStreet
MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results - AlphaStreet
TRxADE: Q3 Earnings Snapshot - Marketscreener.com
Nordic Group makes another acquisition to diversify earnings base - Yahoo Finance
Trxade Health Inc. (NASDAQ: MEDS) Q3 2023 Research Summary - AlphaStreet
Finanzdaten der Scienture Holdings Inc-Aktie (SCNX)
Es liegen keine Finanzdaten für Scienture Holdings Inc (SCNX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.55%
2.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):